Evaluating approaches to patents and pharmaceutical test data protection in selected Southern African Development Community (SADC) member states

Lonias Ndlovu
Additional contact information
Lonias Ndlovu: University of Venda

International Journal of Research in Business and Social Science (2147-4478), 2025, vol. 14, issue 5, 473-481

Abstract: A discussion of pharmaceutical test data protection is a potentially broad area for scholarly investigation. During preclinical and clinical drug testing, test data that evidences safety, effectiveness, and quality is generated to obtain marketing approval by drug regulatory authorities. Depending on the nature of the information and the jurisdiction, such information may be protected as a trade secret or a patent. Protecting patents and pharmaceutical test data in the SADC has significant ethical, legal, and social implications (ELSI). While it is essential to incentivise research and development, it is also crucial to ensure that patients have access to safe and effective medicines and that the public interest is protected. SADC members have diverse approaches and laws on patents and pharmaceutical test data protection. While some countries have comprehensive legal frameworks that balance intellectual property rights with the public interest, others have outdated or incomplete frameworks. The lack or inadequacy of legal frameworks for patents and pharmaceutical test data protection in some SADC countries can negatively affect public health. This paper surveys and calibrates the existing legal frameworks within the SADC region by identifying gaps and suggesting possible law reform solutions inspired by the Trade Related Aspects of Intellectual Property (TRIPS) Agreement, other international frameworks, and comparative law. Using the reward theory as its theoretical lens and linking the main arguments to the obligation of patentees to disclose their inventions fully, the paper concludes that the SADC region requires adequate legal frameworks. Key Words: Pharmaceutical Test Data, Patents, SADC, Drugs, Public Health, Reward Theory, Health Research Ethics

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://ssbfnet.com/ojs/index.php/ijrbs/article/view/3986/2894 (application/pdf)
https://doi.org/10.20525/ijrbs.v14i5.3986 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:rbs:ijbrss:v:14:y:2025:i:5:p:473-481

Access Statistics for this article

International Journal of Research in Business and Social Science (2147-4478) is currently edited by Prof.Dr.Umit Hacioglu

More articles in International Journal of Research in Business and Social Science (2147-4478) from Center for the Strategic Studies in Business and Finance Editorial Office,Baris Mah. Enver Adakan Cd. No: 5/8, Beylikduzu, Istanbul, Turkey. Contact information at EDIRC.
Bibliographic data for series maintained by Umit Hacioglu ().